Clinical Trial

Personalized Brain Stimulation to Help Veterans Quit Smoking

Study acronym: VICTOR
Recruiting
View on ClinicalTrials.gov →
Summary
Cigarette smoking is a significant public health concern for Veterans. Encouraging smoking cessation continues to be a top priority for the Veterans' Administration as Veterans who use tobacco experience negative health effects, including cancer, heart disease, and mental disorders. Despite the efficacy of current evidence-based pharmacotherapies and psychotherapies for smoking cessation, alternative treatments are critically needed. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of brain stimulation, US FDA-approved for smoking cessation. In this protocol, the investigators propose comparing the two rTMS protocols (standard TMS vs. precision TMS) to find a better treatment parameter for smoking cessation in Veterans. Identifying an efficacious rTMS protocol would benefit Veterans who want to quit smoking.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-08-05
critical Recruitment opened 2026-08-01
Trial Details
NCT Number NCT07050862
Lead Sponsor VA Office of Research and Development
Conditions Tabacco Use Disorder, rTMS
Enrollment 56 participants
Start Date 2026-07-01
Primary Completion 2030-04-30 (estimated)
Study Completion 2030-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04